HIV/AIDS Topics IAS 2011: HIV PrEP Effective for Heterosexuals, Discordant Couples
- Details
- Category: HIV Prevention
- Published on Tuesday, 26 July 2011 00:00
- Written by Paul Dalton
Two studies find that pre-exposure prophylaxis (PrEP) with tenofovir or tenofovir/emtricitabine reduces the risk of HIV infection among heterosexuals and serodiscordant couples, researchers reported at IAS 2011.
IAS 2011: HIV Prevention -- A Women's Revolution [VIDEO]
- Details
- Category: HIV Prevention
- Published on Tuesday, 26 July 2011 00:00
- Written by Video
The 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) held last week in Rome heralded remarkable data showing that early HIV treatment and pre-exposure prophylaxis (PrEP) can dramatically reduce the risk of HIV transmission.
But biomedical prevention methods will only work if people have access to them, and many women worldwide do not have access due to lack of economic resources or the right of self-determination.
IAS 2011: HIV Treatment as Prevention: HPTN 052 Offers Proof [VIDEO]
- Details
- Category: Treatment as Prevention
- Published on Tuesday, 19 July 2011 00:00
- Written by Gregory Fowler
HPTN 052 lead investigator Myron Cohen talked to Paul Dalton from HIVandHepatitis.com about the study's findings and their significance. 
IAS 2011: The Proof is Here: HIV Treatment is HIV Prevention
- Details
- Category: Treatment as Prevention
- Published on Tuesday, 19 July 2011 00:00
- Written by Paul Dalton
Antiretroviral treatment was shown to prevent HIV infection in the large, randomized trial HPTN 052 trial, reducing risk by 96%, researchers reported at IAS 2011 this week in Rome.
"There is a clinical benefit for the patient and a dramatic, nearly 100% reduction in transmission," said lead investigator Myron Cohen. "We can't get much better." 
IAS 2011: Changing Face of HIV Vaccine Research [VIDEO]
- Details
- Category: HIV Prevention
- Published on Monday, 18 July 2011 00:00
- Written by Gregory Fowler
Gary Nabel, Director of the National Institutes of Health Vaccine Research Center, presented an overview of the promises and pitfalls of HIV vaccine research in a plenary talk and press conference at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) this week in Rome. 
Web Design and Development by